资讯

PharmiWeb17 分钟
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and ...
Multimodal foundation model enables personalized cognitive forecasts and expands access to Alzheimer's diagnostics - POTOMAC, MD / ACCESS Newswire / July 10, 2025 / IGC Pharma, Inc. (NYSE American:IGC ...